Bortezomib enhances the radiosensitivity of hypoxic cervical cancer cells by inhibiting HIF-1α expression.

He-Qing Cui, Qin Qin, Meilin Yang, Hao Zhang, Zheming Liu, Yan Yang, Xiaochen Chen, Hongcheng Zhu, Di Wang, Cuicui Meng, Hongmei Song, Jianxin Ma, Guanhong Huang, Jing Cai, Xinchen Sun, Zhongming WangPubMed 2015

Abstract

Radiotherapy sensitization of bortezomib on cervical cancer cell lines had a drug-dose relation, and sensitization in hypoxia was more remarkable than in normoxia. Bortezomib may be a potential radiotherapy sensitization drug for cervical cancer.
BibTeX
@inproceedings{cui2015bortezomib,
  author = {He-Qing Cui and Qin Qin and Meilin Yang and Hao Zhang and Zheming Liu and Yan Yang and Xiaochen Chen and Hongcheng Zhu and Di Wang and Cuicui Meng and Hongmei Song and Jianxin Ma and Guanhong Huang and Jing Cai and Xinchen Sun and Zhongming Wang},
  title = {{Bortezomib enhances the radiosensitivity of hypoxic cervical cancer cells by inhibiting HIF-1α expression.}},
  booktitle = {PubMed},
  year = {2015},
}

Loading related content...

Figure